Admescope (www.admescope.com) provides research services to pharmaceutical companies and contributes to the discovery and development of new therapies to promote peoples health. The special expertise of the growing company is in drug metabolism, drug-drug interactions, quantitative bioanalysis, pharmacokinetic studies, and toxicology. The company offers versatile and challenging tasks as a partner of international pharmaceutical and biotech companies. Admescope (Symeres Finland Oy), initially of Finnish origin from 2011, is part of the Dutch company Symeres, which totally employs approximately 600 people in the Netherlands, Finland, the Czech Republic, and the USA (www.symeres.com).